TGA approves new medication for treatment of endometriosis symptoms

Ryeqo is the first oral tablet approved by the TGA for endometriosis pain and also works to prevent excess tissue growth. Photograph: Getty Images

The first new endometriosis treatment in 13 years – aimed at relieving the debilitating pain many with the condition suffer – has been approved by Australia’s drug regulator.

Endometriosis is a chronic condition that occurs when tissue similar to the lining of the uterus grows outside it, affecting other organs and leading to inflammation, lesions and scar tissue.